Defense Department, VA enter partnership to improve veteran care Print E-mail
Tuesday, 13 August 2019 11:00

Washington DC, Aug. 13, 2019 (GLOBE NEWSWIRE)

Washington DC, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Improving veteran care by centralizing the procurement of medical supplies is the goal of an interagency agreement between the Defense Logistics Agency and Department of Veterans Affairs signed at the VA Headquarters in Washington, D.C., Aug. 12.

DLA Director Army Lt. Gen. Darrell Williams and VA Secretary Robert Wilkie formalized the partnership, which is expected to help reduce costs of pharmaceutical national contracts, radiology and imaging contracts, and electronic cataloging.

“In the 21st century, an ad hoc supply chain is not sufficient,” Wilkie said. “It does not do justice to those we are sworn to serve. This is part of not only comprehensive reform of this institution, but it also cements our relationship with the Department of Defense.”

The partnership gives the VA access to DLA Troop Support’s worldwide procurement system for medical and surgical items, cleaning supplies and equipment, construction materials and equipment, and other supplies, according to a VA release. A centralized ordering system will also reduce risk, fraud, waste and abuse when ordering these materials.

“On behalf of the Department of Defense, we are proud to be a value-add to VA on behalf of America’s veterans,” Williams said. “Leveraging economies of scale, like the ones outlined in this agreement, help us reduce costs for the military services and other government partners like VA.”

The agreement is part of DLA’s Whole of Government portfolio, which provides supplies and services to non-DoD agencies, added Dan Strausbaugh, deputy division chief of DLA’s Whole of Government Support Division.

“We’re always reaching out for more business to better streamline certain processes and make the taxpayer’s burden on the federal government less,” he added.


Christine Born  Defense Logistics Agency  571-767-6202  [email protected]  

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit!! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!